期刊文献+

细胞色素P450 2D6*10基因多态性对汉族人群术后吗啡自控镇痛效果的影响 被引量:3

EFFECTS OF CYTOCHROME P-450 2D6*10 GENETIC POLYMORPHISM ON THE POSTOPERATIVE PATIENT-CONTROLLED ANALGESIA WITH MORPHINE IN HAN POPULATION
下载PDF
导出
摘要 目的:评估细胞色素P450 2D6*10基因多态性,对汉族人群术后吗啡自控镇痛效果的影响。方法:美国麻醉医师协会(American Society of Anesthesiologists,ASA)Ⅰ~Ⅱ级患者共64名被纳入此实验,56名患者完成实验。根据CYP2D6基因型,患者分为3组:野生型纯合子组(w/w组,n=19),杂合子组(m/w组,n=21)和突变型纯合子组(m/m组,n=16)。在手术结束前10 min给予复合剂量吗啡(静脉注射,0.1 mg/kg)后,患者可通过吗啡(单次给药1 mg)自控输注泵进行自控镇痛(patient-controlled analgesia,PCA)。全身麻醉诱导后采集血样。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)进行CYP2D6*10基因分型。记录并比较术后72 h各组间的吗啡用量及视觉模拟评分(visual analogue score,VAS)。结果:与m/m组相比,m/w组吗啡在T0.5~4 h的累积量显著升高(P<0.05)。3组中各时间段的VAS评分对比差异无统计学意义。结论:在全麻术后0.5 h至4 h急性疼痛治疗中,CYP2D6*10 m/w组所需吗啡的量比m/m组高,以此推测m/w组产生的内源性阿片肽比m/m组低。 Objective: To evaluate the effects of cytochrome P-450 2D6*10 (CYP2D6*10) genetic polymorphism on the postoperative patient-controlled analgesia with morphine in HAN population. Methods: Totally 64 patients in grades I - II by American Society of Anesthesiologists (ASA) grading were enrolled in this study, among which 56 patients completed the experiment. Patients were categorized into three groups according to the CYP2D6 genotype: wild homozygote (w/w group, n = 19), heterozygote (m/ w group, n = 21) and mutation homozygote (m/m group, n = 16). After receiving a loading dose (i.v. 0.1 mg/kg) in 10 min before the end of operation, patients could conduct patient-controlled analgesia (PCA) by self administration of morphine ( one time 1 mg ) via self-controlled infusion pump. Blood samples were collected after induction of general anesthesia. The CYP2D6*10 genotyping was conducted by means of polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP). The total consumption of morphine and the visual analogue score (VAS) for the three genotype groups within 72 h after the operation were recorded and compared. Results: The cumulative dose of morphine in CYP2D6* 10 m/w group was significantly higher than that in the m/m group at T0.5 - 4 h (P 〈 0.05). There was no significant difference of VAS among three groups within 72 h after the operation. Conclusion: The current results suggested that CYP2D6* 10 m/w group appeared to require more morphine in the acute operative period (0.5 - 4 h after operation) compared with CYP2D6*10 m/m group. One possible mechanism for this observation is that CYP2D6*10 m/w group may have lower efficiency in synthesizing endogenous opioid peptide compared with CYP2D6* 10 m/m group.
出处 《中国疼痛医学杂志》 CAS CSCD 北大核心 2013年第9期540-544,共5页 Chinese Journal of Pain Medicine
关键词 CYP2D6*10 内源性阿片肽 基因多态性 术后镇痛 吗啡 CYP2D6*10 Endogenous opioid peptide Genetic polymorphisms Postoperative analgesia Morphine
  • 相关文献

参考文献15

  • 1Zhu W, Cadet P, Baggermen G, et al. Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol, 2005,175:7357 - 7362. 被引量:1
  • 2袁红斌,王成才,王新华.阿片肽外周镇痛机理的研究进展及临床应用[J].中国疼痛医学杂志,2002,8(1):31-34. 被引量:14
  • 3Kilpatrick G J, Smith TW. Morphine-6-glucuroni- de: actions and mechanisms. Med Res Rew, 2005, 25:521 - 544. 被引量:1
  • 4Candiott KA, Yang Z, Rodriguez Y, et al. The impact of CYP2D6 genetic polymorphisms on postoperative morphine consumption. Pain Med, 2009, 10:799 - 805. 被引量:1
  • 5Somogyi AA, Barrat DT, Coller JK. Pharmacoge- netics of opioids. Clin Pharmacol Ther, 2007, 81:429 - 444. 被引量:1
  • 6Gadeyne C, Van der Heyden S, Gasthuys F, et al. The influence of modulation of P-glycoprotein and/ or cytochrome P450 3A on the pharmacokinetics and pharmacodynamics of orally administered morphine in dogs. J Vet Pharmacol Ther, 2011, 34:417 - 423. 被引量:1
  • 7Kubota T, Yamaura Y, Ohkawa N, et al. Frequenc- ies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes. Br J Clin Pharmacol, 2000, 50:31 - 34. 被引量:1
  • 8Hiroi T, Imaoka S, Funae Y. Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun, 1998, 249:838 - 843. 被引量:1
  • 9Sindrup SH, Poulsen L, Brosen K, et al. Are poor metabolisers of sperteine/debrisoquine less pain tolerant than extensive metabolisers. Pain, 1993, 53:335 - 339. 被引量:1
  • 10Funae Y, Kishimoto W, Cho T, et al. CYP2D in the brain. Drug Metab Pharmacokinet, 2003, 18:337 - 349. 被引量:1

二级参考文献20

  • 1Inoue M, Ueda H, et al. Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin nociception test in mice. J Pharmacol Exp Ther, 2000,293:662~669. 被引量:1
  • 2Ueda H, Yamaguchi T, Tokyama S, et al. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett, 1997,237:136~138. 被引量:1
  • 3Ueda H, Inoue M. Peripheral morphine analgesia resistant to tolerance in chronic morphine treated mice. Neurosci Lett, 1999,266:105~108. 被引量:1
  • 4Stein C, Comisel K, Haimerl E. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med, 1991, 325:1123~1126. 被引量:1
  • 5Likar R, Schafer M, Paulak F, et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg, 1997,84:1313~1317. 被引量:1
  • 6Stein C, Hassan AHS, Lehrberger K, et al. Local analgesic effect of endogenous opioid peptides. Lancet, 1993,342:321~324. 被引量:1
  • 7Kolesnikov YA, Jain S, Wilson R, et al. Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance. J Pharmacol Exp Ther,1996,279:502~506. 被引量:1
  • 8Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg, 1993,76:182~191. 被引量:1
  • 9Buerkle H, Boschin M, Marcus MA, et al. Central and peripheral analgesia mediated by the acetylcholinesterase inhibitor neostigmine in the rat infoamed knee joint model. Anesth Analg, 1998,86:1027~1032. 被引量:1
  • 10Hassan AHS, Ableitner A, Stein C, et al. Inflammation of the rat paw enhancesaxonal transport of opioid receptors in the sciatic nerve an increases their density in the inflamed tissue. Neuroscience, 1993,55:1185~1195. 被引量:1

共引文献13

同被引文献31

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部